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J3R, the 39-kDa subunit of vaccinia virus poly(A) polymerase, is a multifunctional protein that catalyzes (nucleoside-29-
O-)-methyltransferase activity, serves as a poly(A) polymerase stimulatory factor, and acts as a postreplicative positive
transcription elongation factor. Prior results support an association between poly(A) polymerase and the virion RNA
polymerase. A possible direct interaction between J3R and H4L subunit of virion RNA polymerase was evaluated. J3R was
shown to specifically bind to H4L amino acids 235–256, C terminal to NPH I binding site on H4L. H4L binds to the C-terminal
region of J3R between amino acids 169 and 333. The presence of a J3R binding site near to the NPH I binding region on H4L
led us to evaluate a physical interaction between NPH I and J3R. The NPH I binding site was located on J3R between amino
acids 169 and 249, and J3R was shown to bind to NPH I between amino acids 457 and 524. To evaluate a role for J3R in early
gene mRNA synthesis, transcription termination, and/or release, a transcription-competent extract prepared from cells
infected with mutant virus lacking J3R, J3-7. Analysis of transcription activity demonstrated that J3R is not required for early
mRNA synthesis and is not an essential factor in early gene transcription termination or transcript release in vitro. J3R
interaction with NPH I and H4L may serve as a docking site for J3R on the virion RNA polymerase, linking transcription to
mRNA cap formation and poly(A) addition. © 2001 Academic Press
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Vaccinia virus, the prototypical member of the or-
thopoxvirus family, is unique among DNA viruses in that
it replicates entirely in the cytoplasm of the infected cell
(for review, see Moss, 1996). As a consequence, vaccinia
virus encodes most of the enzymes needed for viral gene
expression and DNA replication. As a result, vaccinia
virus has served as a useful model system for investi-
gating the basic mechanisms of RNA and DNA metabo-
lism.
Vaccinia virus gene expression is divided into three
temporal classes, early, intermediate, and late. This tem-
poral regulation of gene transcription is mediated by the
timed synthesis of class-specific transcription initiation
factors. Early genes are transcribed in the virus core
immediately after infection; intermediate genes are tran-
scribed in the cytoplasm subsequent to the onset of DNA
Abbreviations: GST, glutathione S-transferase; SDS, sodium dodecyl
sulfate; PAGE, polyacrylamide gel electrophoresis; NPH I, nucleoside
triphosphate phosphohydrolase I; VTF, vaccinia termination factor;
RAP94, RNA polymerase-associated protein 94 kDa; IBT, isatin-b-thio-
semicarbazone; CTD, carboxy-terminal domain.
1 To whom reprint requests should be addressed at Department of
Microbiology and Biochemistry, 138 Farber Hall, SUNY, Buffalo, NY
14214. Fax: (716) 829-2169. E-mail: eniles@buffalo.edu.
143replication and require prior early gene expression; late
gene transcription follows the intermediate genes and
requires the synthesis of three intermediate proteins
(Moss, 1990). Host factors are also employed in both
intermediate (Rosales et al., 1994) and late (Gunasinghe
et al., 1998; Zhu et al., 1998) mRNA synthesis. Initiation of
early vaccinia virus transcription requires the early tran-
scription factor VETF (Broyles et al., 1988) and virion RNA
polymerase possessing the RNA polymerase-associated
protein RAP94, the product of H4L gene (Ahn and Moss,
1992; Deng and Shuman, 1994).
The structure of intermediate and late vaccinia virus
mRNAs differs significantly from the structure of early
viral mRNAs primarily as a result of differences in forma-
tion of mRNA 39 ends (Mahr and Roberts, 1984). Early
gene transcription is actively terminated in response to a
conserved sequence element, UUUUUNU, in the nascent
mRNA (Yuen and Moss, 1987). Early viral mRNAs are
therefore discrete in size. In contrast, at intermediate and
late times during infection, early termination signals are
ignored, and most intermediate and late transcripts do
not appear to be terminated at unique sites on the
genome (Mahr and Roberts, 1984). However, analyses of
the mechanism of 39 end formation of the late mRNA
encoding the major protein component of the A-type
inclusions (in cowpox virus, the 160-kDa protein encoded
by the ati gene) showed that these 39 ends are generated
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Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
[
t
a
o
1
s
s
t
s
a
(
i
a
R
t
R
m
e
p
i
e
t
b
I
t
l
p
b
p
p
N
F
m
r
I
R
a
o
u
S
l
c
w
S
g
b
b
N
X
R
144 MOHAMED ET AL.by site-specific RNA cleavage (Antczak et al., 1992;
Howard et al., 1999). In vitro only the virion RNA poly-
merase capable of recognizing early promoters is sub-
ject to signal-dependent termination, indicating that this
form of RNA polymerase is uniquely termination compe-
tent (Condit et al., 1996). Termination requires both the
vaccinia termination factor (VTF; also serves as viral
mRNA capping enzyme) (Shuman et al., 1987) and nucle-
oside triphosphate phosphohydrolase I (NPH I), the prod-
uct of D11L gene, as the ATPase employed in transcrip-
tion termination (Christen et al., 1998; Deng and Shuman,
1998). A recent report by Mohamed and Niles (2000)
demonstrated that a physical interaction between H4L
subunit of virion RNA polymerase and NPH I is required
for transcript release in vitro. This interaction explains
the observed restriction of transcription termination to
early viral genes and defines H4L as a termination co-
factor (Mohamed and Niles, 2000).
J3R, the small subunit of vaccinia virus poly(A) poly-
merase (Gershon et al., 1991; Schnierle et al., 1992), is a
multifunctional polypeptide. In the virion, J3R is present
in a fivefold molar excess over E1L, the catalytic subunit
of poly(A) polymerase, and therefore exists both in mo-
nomeric form and in association with E1L (Gershon et al.,
1991). Although it lacks polyadenylation catalytic activity
(Gershon et al., 1991), J3R dramatically accelerates E1L
catalytic extension of either mRNA 39-end primers with
short oligo(A) tails, or poly(A) primers (Gershon and
Moss, 1993). J3R has a second, entirely unrelated func-
tion, catalyzing the conversion of the mRNA 59 cap O
[m7G(59)pppN] structure to its cap 1 counterpart
m7G(59)pppNm] by methylation of the ribose moiety of
he first transcribed nucleotide of the mRNA (Schnierle et
l., 1992). Both the monomeric and heterodimeric forms
f J3R exhibit methyltransferase activity (Schnierle et al.,
992). A recent report by Latner et al. (2000) demon-
trates that J3R serves as a postreplicative positive tran-
cription elongation factor during a normal virus infec-
ion. Compared to wild-type virus infections, J3R mutants
ynthesize reduced amounts of large late viral proteins
nd shorter-than-normal intermediate and late mRNAs
Xiang et al., 2000). The elongation factor activity of J3R is
ndependent of the poly(A) stimulatory activity (Xiang et
l., 2000).
Prior work by Zhang et al. (1994) showed that nascent
AP94-deficient virus core particles exhibit low or unde-
ectable amounts of several viral enzymes, including viral
NA polymerase, capping enzyme, NPH I, poly(A) poly-
erase, topoisomerase, and RNA helicase. The pres-
nce of these unpackaged viral enzymes in the cyto-
lasm indicated that RAP94 (H4L) is required for target-
ng a complex of functionally related proteins involved in
arly mRNA synthesis. Several observations made over
he past few years have forged strong molecular links
etween transcription by nuclear RNA polymerase II (PolI) and pre-mRNA processing. The key findings supporthe view that the carboxy-terminal domain (CTD) of the
arge subunit of RNA polymerase II binds directly to
rotein factors essential for RNA processing (Neuge-
auer and Roth, 1997). The presence of a nuclear RNA
ol II transcription/processing complex suggests the
ossibility of such a complex in vaccinia virus.
In this report, we demonstrate that J3R binds to both
PH I and the H4L subunit of the viral RNA polymerase.
urthermore, we show that J3R is not required for early
RNA synthesis, transcription termination or transcript
elease in vitro.
RESULTS
nteraction between J3R and H4L subunit of virion
NA polymerase
The GST-pulldown approach was employed to evalu-
te possible interactions between J3R, the small subunit
f vaccinia virus poly(A) polymerase, and the H4L sub-
nit of virion RNA polymerase. To this end, glutathione–
epharose coupled with GST-J3R was mixed with 35S-
abeled, in vitro-synthesized H4L protein. As a negative
ontrol, glutathione–Sepharose resin coupled with GST
as mixed with an equal amount of 35S-H4L. Compared
to a resin-linked GST, GST-J3R bound to H4L (Fig. 1A),
indicating that there is a direct interaction between J3R
and H4L subunit of virion RNA polymerase. To confirm
FIG. 1. J3R interacts with the H4L subunit of virion RNA polymerase.
A coupled transcription/translation system was employed to synthesize
35S-H4L or 35S-J3R. GST-J3R and His-GST-H4L were purified from the
100 fraction of the induced E. coli cells by batchwise affinity to
lutathione–Sepharose. One microliter of the translation mix was incu-
ated with 25 ml of glutathione–Sepharose resin (50:50 slurry) coupled
to 1 mg of GST-fusion protein of interest at 4°C overnight in binding
uffer [25 mM Tris–HCl, pH 8.0, 1 mM EDTA, 10% glycerol (w/v), 50 mM
aCl]. The resin was washed and analyzed by SDS–PAGE followed by
-ray autoradiography. (A) The association of the H4L subunit of virion
NA polymerase, 35S-H4L, with the small subunit of poly(A) polymerase,
GST-J3R, is demonstrated. (B) The association of 35S-J3R with His-GST-
H4L is demonstrated. I, 50% of the input radioactivity; G, resin-bound
GST; G-J3R, resin-bound GST-J3R; H-G, resin-bound His-GST; H-G-H4L,
resin-bound His-GST-H4L. The percent binding (indicated below the
autoradiograph) was quantified by scanning the autoradiogram with a
PhosphorImager.this interaction, glutathione–Sepharose coupled with
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145VACCINIA VIRUS TRANSCRIPTION RNA PROCESSING COMPLEXHis-GST-H4L was mixed with an 35S-labeled, in vitro-
ynthesized J3R protein. Compared to a resin-linked His-
ST, His-GST-H4L bound to J3R (Fig. 1B).
3R binds to H4L amino acids 235–256
In an attempt to map the site of interaction of J3R on
4L, a battery of N- and C-terminal truncation mutations
f H4L was constructed in pCITE-4a (Mohamed and
iles, 2000) (Fig. 2A). Each of these truncations was
ynthesized in vitro as 35S-labeled protein. Each of the N-
and C-terminal truncation mutations of H4L was mixed
with GST-J3R coupled to glutathione–Sepharose. Com-
pared to a GST negative control, all of the C-terminal
deletion mutations of H4L, except the smallest N-termi-
nal region of H4L (1–195), bound to GST-J3R (Fig. 2B).
Furthermore, GST-J3R was able to pull down the N-
terminal deletion mutation of H4L (235–795) mapping the
site of interaction of J3R to H4L between amino acids 235
and 288. In confirmation, a mal fusion possessing the
N-terminal third of H4L (representing amino acids 1–256)
FIG. 2. J3R binds to H4L amino acids 235–256. (A) A series of N- and
C-terminal truncation mutations of H4L was constructed and expressed
in vitro in a coupled transcription/translation system. Numbers denote
the H4L amino acids present in each protein fragment. (B) The asso-
ciation of GST-J3R with a set of 35S-H4L truncation mutations is dem-
onstrated. Resin-bound proteins were separated by gel electrophore-
sis, and H4L proteins were identified by autoradiography. The N-
terminal truncation mutant of H4L (235–795) bound GST-J3R. I, 50% of
the input radioactivity; G, resin-bound GST; GJ, resin-bound GST-J3R.
The percent binding (indicated below the autoradiograph) was quanti-
fied by scanning the autoradiogram with a PhosphorImager. For 35S-2
4L1-338, background value of 3.6% was subtracted. (C) The association
f Mal-fusion of H4L fragments with 35S-J3R is demonstrated.was able to pull down 35S-J3R (Fig. 2C), demonstrating
hat the region between amino acids 235 and 256 is
ecessary for productive binding of J3R to the N-terminal
egion of H4L.
4L binds to J3R amino acids 169–333
To map the site on J3R that interacts with H4L, a
attery of N- and C-terminal truncation mutations of J3R
as constructed both in pET-42a and pCITE-4a vectors
Fig. 3A). Each truncation was either expressed in vitro in
n Escherichia coli expression system or synthesized in
itro as 35S-labeled protein. Glutathione–Sepharose res-
ins, coupled with His-GST-fusion of either WT J3R or
each truncation mutant, were mixed with 35S-H4L1-288 and
inding was evaluated. Compared to a His-GST-negative
ontrol, only J3R truncations 59D1 and 59D2 (representing
mino acids 83–333 and 169–333, respectively) were
apable of pulling down 35S-H4L1-288 (Fig. 3B). These
results demonstrate that the N-terminal region of H4L
(1–288) interacts with the C-terminal region of J3R (169–
333). The fact that J3R truncations 39D1 and 59D3 (rep-
resenting amino acids 1–249 and 251–333, respectively)
failed to bind 35S-H4L1-288 suggests that H4L binding site
n J3R may reside in the region centered on amino acid
FIG. 3. H4L binds to J3R amino acids 169–333. (A) A series of N- and
C-terminal truncation mutations of J3R was constructed and expressed
in vitro in an E. coli expression system. Induction of GST fusion of wild
type as well as truncation mutations of J3R was carried out at 20°C.
His-GST fusions of full-length J3R or a set of truncation mutations were
purified from the S100 fraction of the induced cells by batchwise affinity
to glutathione–Sepharose. Numbers denote the J3R amino acids
present in each protein fragment. (B) The association of His-GST
fusions of full-length J3R or a set of truncation mutations with the
35S-labeled N-terminal region of H4L (1–288) is demonstrated. I, 50% of
he input radioactivity; HG, His-GST. The percent binding (indicated
elow the autoradiograph) was quantified by scanning the autoradio-
ram with a PhosphorImager.50.
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146 MOHAMED ET AL.J3R binds NPH I
A recent report by Mohamed and Niles (2000) demon-
strated a physical interaction between H4L subunit of
virion RNA polymerase and nucleoside triphosphate
phosphohydrolase I (NPH I; a ssDNA-dependent
ATPase). This interaction was mapped to the N-terminal
195 amino acids of H4L and the C-terminal end of NPH
I (Mohamed and Niles, 2000). The finding that J3R binds
to the N-terminal region of H4L between amino acids 235
and 256 (Figs. 2B and 2C), C-terminal to NPH I binding
site, led us to test for a possible interaction between J3R
and NPH I. To this end, glutathione–Sepharose coupled
with GST-J3R was mixed with an 35S-labelled, in vitro-
ynthesized NPH I protein. As a negative control, gluta-
hione–Sepharose resin coupled with GST was mixed
ith an equal amount of 35S-NPH I. Compared to a resin
inked GST, GST-J3R bound to NPH I (Fig. 4A) demon-
trating direct interaction between J3R and NPH I. In an
ttempt to confirm this observation, glutathione–Sepha-
ose coupled with GST-NPH I was mixed with an 35S-
labelled, in vitro-synthesized J3R protein. Compared to a
resin linked to GST, GST-NPH I bound to J3R (Fig. 4B).
NPH I binds to J3R amino acids 169–249
To map the site of NPH I interaction on J3R, we em-
ployed the battery of J3R truncation mutants (Fig. 3A) in a
pull-down experiment. Each of the J3R truncations was
synthesized in vitro as an 35S-labeled protein. Glutathione–
Sepharose coupled with GST-NPH I was mixed with
each of the 35S-labeled J3R truncations. Wild-type J3R
was included as a positive control. As a negative control,
glutathione–Sepharose resin coupled with GST was
mixed with an equal amount of each of the 35S-labeled
proteins. Compared to a wild-type positive control, J3R
FIG. 4. J3R binds NPH I. A coupled transcription/translation system
was employed to synthesize 35S-NPH I or 35S-J3R. Induction of GST-
fusion of NPH I or J3R was carried out at 20°C. (A) The association of
35S-NPH I, with the small subunit of poly(A) polymerase, GST-J3R, is
emonstrated. (B) The association of 35S-J3R with GST-NPH I is dem-
nstrated. I, 50% of the input radioactivity; G, resin-bound GST; G-J3R,
esin-bound GST-J3R; G-NPH I, resin-bound GST-NPH I. The percent
inding (indicated below the autoradiograph) was quantified by scan-
ing the autoradiogram with a PhosphorImager.truncations, 59D1, 59D2, and 39D1 (representing amino
acids, 83–333, 169–333, and 1–249), maintained a mini-
mum of 50% of the WT binding efficiency to GST-NPH I
(Fig. 5). These results map the site of interaction be-
tween NPH I and J3R to the C-terminal half of J3R be-
tween amino acids 169 and 249, apparently N-terminal to
the H4L interaction region on J3R.
J3R binds to NPH I amino acids 457–524
Previous evaluation of NPH I carboxyl terminal dele-
tion mutations indicated that the carboxyl terminal end of
NPH I (603–631) interacts with H4L subunit of virion RNA
polymerase (Mohamed and Niles, 2000). The ability of
each NPH I C-terminal deletion mutation to interact with
J3R was assessed directly. Each of these truncation
mutants was expressed as GST fusion, coupled to glu-
tathione–Sepharose and mixed with equal amounts of
35S-J3R. GST fusion of wild-type NPH I was used as a
ositive control. Compared to a GST-negative control,
PH I C-terminal deletions, 39D1, 39D2, and 39D3, repre-
enting amino acids 1–603, 1–563, and 1–524, respec-
ively, bound to 35S-J3R (Fig. 6, top). In confirmation of
these results, GST-J3R bound to 35S-labeled NPH I C-
erminal deletions, 39D1, 39D2, and 39D3 (representing
mino acids 1–603, 1–563, and 1–524, respectively) (not
hown). Moreover, a Ni–agarose resin coupled with His6-
agged-NPH I457-631 was capable of pulling down
35S-J3R,
compared to a Ni–Agarose-negative control (Fig. 6, bot-
tom). These results demonstrate that J3R binds NPH I
between amino acids 457 and 524, a site that is N-
terminal to the H4L binding site on NPH I.
J3R is not required for early gene transcription
termination in vitro
A recent report showed that an interaction between
FIG. 5. NPH I binds to J3R amino acids 169–249. A coupled tran-
scription/translation system was employed to synthesize full-length
35S-J3R or a set of truncation mutations. The association of GST-NPH I
ith full-length J3R or a set of truncation mutations is demonstrated. I,
0% of the input radioactivity; G, resin-bound GST; GN, resin-bound
ST-NPH I. The percent binding (indicated below the autoradiograph)
as quantified by scanning the autoradiogram with a PhosphorImager.H4L subunit of virion RNA polymerase and NPH I, a
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147VACCINIA VIRUS TRANSCRIPTION RNA PROCESSING COMPLEXssDNA-dependent ATPase, is required for early gene
transcription termination and transcript release (Mo-
hamed and Niles, 2000). Moreover, Latner et al. (2000)
concluded that J3R is a postreplicative positive transcrip-
tion elongation factor. Our observation that J3R interacts
with both NPH I and H4L suggested a possible role for
J3R in early gene mRNA synthesis and in transcription
termination and transcript release. However, Xiang et al.
(2000) observed apparently proper early gene transcrip-
tion in J3R mutant virus-infected cells. In an attempt to
further evaluate the role of J3R in early gene transcrip-
tion, the following in vitro analyses were conducted. A
transcription competent extract was prepared from cells
infected with mutant virus lacking J3R (Latner et al.,
2000). The ability of the J3R mutant virus-infected cell
extract to mediate early gene transcription termination
and/or release was next assessed. To test the ability of
the J3R mutant virus-infected cell extract to mediate early
gene transcription termination, the pSB24-term plasmid
template (Condit et al., 1996) was used (Fig. 7A). The
plasmid template was designed to contain a G-less cas-
sette possessing a tandem early gene transcription ter-
mination signal downstream from a strong synthetic vac-
cinia virus early promoter (Condit et al., 1996). Synthesis
of a transcript that extends from the initiation site to the
end of the G-less cassette would yield a product of ;540
bases in length. Signal-dependent termination would be
expected to produce a family of RNA products ;450
bases in length. Transcription of pSB24-term was carried
FIG. 6. J3R binds to NPH I amino acids 457–524. A coupled tran-
cription/translation system was employed to synthesize 35S-J3R. Top,
the association of GST fusions of full-length NPH I or a set of C-terminal
truncation mutations with 35S-J3R is demonstrated. Bottom, the associ-
ation of His6 fusion of NPH I457-631 with
35S-J3R is demonstrated. Bottom
panel: background value of 5% was subtracted. I, 50% of the input
radioactivity; GST, resin-bound GST; R, Ni–agarose resin alone. The
percent binding (indicated below the autoradiograph) was quantified by
scanning the autoradiogram with a PhosphorImager.out in the presence or absence of exogenously added
VTF and various levels of J3R, and the RNA products
were analyzed by gel electrophoresis (Fig. 7B). Virus-
infected cell extracts are deficient in VTF to various
degrees (Condit et al., 1996). Addition of VTF enhanced
the level of termination to ;70%. However, addition of
pure J3R did not alter total RNA synthesis and had no
effect on the overall termination process. In addition,
measurement of the early gene transcription elongation
rate, in vitro, in the absence of J3R was indistinguishable
from that done in the presence of J3R (not shown). These
results demonstrate that J3R is not required for early
mRNA synthesis or for transcription termination in vitro.
FIG. 7. J3R is not required for early gene transcription termination in
vitro. (A) A map of the pSB24-term template is shown (Condit et al.,
1996). Synthesis of a transcript that extends from the initiation site to
the end of the G-less cassette would yield a product of ;540 bases in
length. Signal-dependent termination would be expected to produce a
family of RNA products ;450 bases in length. P, early gene promoter;
T, termination signal. (B) Transcription reactions were carried out in 20
ml total volume containing 6 ml of J3R-mutant extract (lacking J3R), 1
mM ATP, 0.1 mM UTP, 20 mM CTP, 4 mCi [a-32P]CTP (800 Ci/mmole), 0.1
mM 39OMeGTP, 0.2 mg supercoiled plasmid DNA, 20 mM Tris buffer,
H 8.0, 6 mM MgCl2, 2 mM dithiolthreitol, and 8% glycerol. After
roteinase K treatment, RNA was isolated by extraction with phenol/
hloroform, precipitated with isopropanol, and resuspended in form-
mide dye. Samples were heated at 90°C, separated by electrophore-
is in 5% acrylamide 8 M urea gels, and the RNA was visualized by
utoradiography. Termination efficiency (indicated below the autoradio-
raph) was calculated as the molar ratio of terminated RNA to the sum
f read through and terminated RNA, using a PhosphorImager. CE,
apping enzyme.Furthermore addition of J3R does not influence early
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148 MOHAMED ET AL.gene transcription, indicating that it is not a regulator of
these events.
The ability of the J3R mutant virus-infected cell extract
to mediate early gene transcript release from bead
bound ternary complexes, in the presence or absence of
exogenously added J3R, was tested. The prototype
G21(TER29)A78 transcription unit (Deng et al., 1996) con-
sists of a synthetic early promoter fused to a 20-nucleo-
tide G-less cassette, which is flanked by a run of three G
residues at positions 121 to 123. A 57-nucleotide A-less
assette was inserted downstream of the G-less cas-
ette and flanked at its 39 end by a run of four A residues
t positions 178 to 181. A termination signal,
TTTTTTTT, was placed within the A-less cassette, span-
ing positions 129 to 137 (Fig. 8A). The use of bead-
ound DNA template provided a convenient method to
ssay transcript release by magnetic separation of tem-
late-engaged 32P-labeled RNA products (bead-bound)
from released transcripts in the supernatant. The labeled
RNAs that had extended to A78, in the J3R-mutant virus
infected cell extracts lacking J3R (Latner et al., 2000),
were recovered in the template-bound fraction and then
incubated with 1 mM dATP, VTF/CE, J3R, and E1L. The
addition of VTF alone was capable of enhancing the level
transcript release from the arrested ternary complex (Fig.
8B). However, the addition of J3R, either alone and in
combination with E1L, failed to have any significant ef-
fect on the release process (Fig. 8B). These results
indicate that J3R is not an essential cofactor for early
gene transcript release in vitro.
DISCUSSION
J3R, the small subunit of vaccinia virus poly(A) poly-
merase (Gershon et al., 1991; Schnierle et al., 1992), is a
multifunctional protein. In the virion, J3R is present in a
fivefold molar excess over E1L, the catalytic subunit of
poly(A) polymerase, and therefore exists both free and
associated with E1L (Gershon et al., 1991). Although J3R
lacks polyadenylation catalytic activity (Gershon et al.,
1991), it dramatically accelerates E1L catalytic extension
of either mRNA 39-end primers with short oligo(A) tails or
poly(A) primers (Gershon and Moss, 1993). J3R has a
second, entirely unrelated function, catalyzing the con-
version of the mRNA 59 cap O [m7G(59)pppN] structure to
its cap 1 counterpart [m7G(59)pppNm] by methylation of
the ribose moiety of the first transcribed nucleotide of the
mRNA (Schnierle et al., 1992). Both the monomeric and
heterodimeric forms of J3R exhibit methyltransferase ac-
tivity (Schnierle et al., 1992). In addition, a recent report
by Latner et al. (2000) showed that J3R is a postreplica-
tive positive transcription elongation factor during a nor-
mal virus infection. The elongation factor activity of J3R is
independent of the poly(A) stimulatory activity (Xiang et
al., 2000).Prior results support an interaction between poly(A)polymerase and the virion RNA polymerase. Work by
Zhang et al. (1994) demonstrated that nascent RAP94-
deficient virus core particles, lacking the H4L subunit,
exhibit low or undetectable amounts of several viral
enzymes including viral RNA polymerase, capping en-
zyme, NPH I, poly(A) polymerase, topoisomerase, and
RNA helicase. The presence of these unpackaged viral
enzymes in the cytoplasm indicated that RAP94 is re-
quired for targeting a complex of functionally related
proteins required for early gene transcription and mRNA
processing. Multiple proteins employed in mRNA synthe-
sis and mRNA cap and poly(A) formation appear to bind
either directly or indirectly to H4L subunit of virion RNA
FIG. 8. J3R is not required for early gene transcript release from an
arrested ternary complex in vitro. (A) A map of the bead bound
G21(TER29) A78 DNA template is shown (Deng et al., 1996). The DNA
template is uniquely biotinylated at the 59 end of the non template
strand, which anchors the DNA to streptavidin-coated magnetic beads.
The transcription unit consists of a synthetic early promoter fused to a
20-nucleotide G-less cassette, which is flanked by a run of three G
residues at positions 121 to 123. A 57-nucleotide A-less cassette was
inserted downstream of the G-less cassette and flanked at its 39 end by
four A residues at positions 178 to 181. A termination signal,
TTTTTTTTT, was placed within the A-less cassette, spanning position
129 to 137. Arrows represent the products produced by the various
reaction conditions. FL, full length; P, promoter; term, termination prod-
uct. (B) Ternary complexes containing the G21 transcript, were synthe-
sized in a J3R mutant virus-infected cell extract (lacking J3R), ATP, CTP,
UTP, and 39 OMeGTP. The ternary complexes were then isolated and
the nascent transcript was extended through the A-less cassette, in the
presence of UTP, GTP, CTP, and cordycepin triphosphate, to yield a
bead-bound ternary complex containing the A78 transcript. Transcript
release from the paused ternary complex was then assessed in the
presence or absence of VTF, trx-J3R, or mal-E1L. The bead-bound A78
RNA (lane B; bound) was separated from released A78 RNA (lane F;
free) by centrifugation. The transcription products were analyzed by
electrophoresis through a 12% polyacrylamide gel containing 8 M urea.
The labeled A78 transcript was visualized by autoradiography. The
percent of RNA released (indicated below the autoradiograph) was
quantified by scanning the autoradiogram with a PhosphorImager. CE,
capping enzyme.polymerase, suggesting the formation of a viral transcrip-
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149VACCINIA VIRUS TRANSCRIPTION RNA PROCESSING COMPLEXtion/mRNA processing complex. Results from our labo-
ratory showed that E1L, the catalytic subunit of vaccinia
poly(A) polymerase, does not bind H4L (unpublished
data). Therefore, a possible direct interaction between
J3R subunit of vaccinia virus poly(A) polymerase and H4L
subunit of virion RNA polymerase was evaluated. J3R
was shown to bind specifically to H4L, and, using a
series of N- and C-terminal truncation mutations of H4L,
the site of interaction of J3R was mapped to the N-
terminal region of H4L between amino acids 235 and 256
and the site of interaction of H4L was mapped to the
C-terminal region of J3R between amino acids 169 and
333. The J3R binding site on NPH I was mapped between
amino acids 457 and 524, and the NPH I binding site on
J3R was located between amino acids 169 and 249. The
H4L interaction site on J3R appears to be C-terminal to
the NPH I binding site on J3R.
X-ray crystal structure of J3R presents a compact sin-
gle-domain protein with a typical a/b fold (Hodel et al.,
1996). The central portion of the polypeptide chain folds
into a core structure in which a mixed seven-stranded
twisted b-sheet structure is surrounded by parallel a
helices. The protein envelope resembles a highly oblate
sphere with one face bisected by a cleft, the cleft face
(Hodel et al., 1996). The face of J3R opposite to the cleft,
the flat face, is formed from the loops N terminal to each
of the seven b strands and by the three C-terminal
helices appended to the core structure. E1L was re-
ported to bind to the flat face of J3R, with a 3- to 5-residue
“hot-spot,” which is sensitive to amino acid substitutions,
including Arg-55, His-56, Ile-58, Cys-272, and Tyr-271 (Shi
et al., 1997). In this report, we demonstrated that NPH I
bound to the C-terminal region of J3R (169–249) that
occupies a significant part of the flat face of J3R, yet
away from E1L interaction site with J3R. In addition, none
of the residues in the E1L interaction site is located
within the mapped binding region for NPH I (169–249).
Data indicate that H4L binds C terminal to NPH I on J3R.
Therefore, the J3R N-terminal residues required for E1L
interaction are not needed for H4L interaction. Moreover,
E1L addition does not reduce the binding of either H4L or
NPH I to J3R in vitro (not shown), demonstrating that the
E1L binding site on J3R does not overlap that of NPH I
and H4L.
Since the interaction between NPH I and H4L is re-
quired for early gene transcription termination and tran-
script release (Mohamed and Niles, 2000), the observed
interaction of J3R with both NPH I and H4L suggested
that J3R might play a role in early gene mRNA synthesis,
transcription termination, transcript release, or regula-
tion of these processes. To evaluate this possibility, RNA
synthesis from an early promoter was measured in a
transcription-competent extract prepared from cells in-
fected with mutant virus lacking J3R (Latner et al., 2000).
otal RNA synthesis appeared normal in the absence of
3R. In addition, measurement of the early gene tran-cription elongation rate in the absence of J3R, in vitro,
as indistinguishable from that done in the presence of
3R (not shown). Exogenously added VTF enhanced the
evel of termination to ;70%, in the absence of J3R.
hese results demonstrate that J3R is not required for
arly mRNA synthesis or for early gene transcription
ermination in vitro. Moreover, addition of pure J3R did
ot exhibit any effect on the overall termination process,
emonstrating that J3R is not a modulator of early gene
ranscription termination in vitro. These results are con-
istent with the in vivo observation of Xiang et al. (2000),
ho showed that infection with J3R mutant viruses ex-
ibited early gene expression that is indistinguishable
rom that in a wild-type virus infection. Analysis of tran-
cript release activity of ternary complexes prepared
rom virus-infected cell extracts lacking J3R demon-
trated that J3R is not required for this final step in
ranscription. These results demonstrate that J3R is not
n essential factor in early gene mRNA synthesis, tran-
cription termination and/or release in vitro. Alternatively,
NPH I and H4L may serve as a docking site for J3R on the
virion RNA polymerase, linking the transcription machin-
ery to an enzyme employed in mRNA processing at both
the 59 and the 39 ends.
The presence of nuclear transcription/RNA processing
complex has been the subject of much research activity.
Increasing evidence supports the presence of such com-
plex in eukaryotic nuclei. Several observations made
over the past few years have forged strong molecular
links between transcription by RNA polymerase II (Pol II)
and pre-mRNA processing. Biochemical studies have
shown that RNA polymerase II, via the CTD, can physi-
cally interact with capping enzymes (Cho et al., 1997;
McCracken et al., 1997a; Yue et al., 1997), polyadenyla-
tion factors (McCracken et al., 1997b), and splicing fac-
tors, including both snRNPs and SR-like proteins (Chabot
et al., 1995; Kim et al., 1997; Mortillaro et al., 1996; Yuryev
et al., 1996). In addition, in vivo studies using mammalian
cells in culture have demonstrated that RNAs synthe-
sized by RNA polymerase II with a shortened CTD un-
dergo inefficient capping, splicing, and polyadenylation
(McCracken et al., 1997a,b) and that overexpression of
phosphorylated CTD peptides inhibits splicing (Du and
Warren, 1997).
Because of its large size and multisubunit composition
(Baroudy and Moss, 1980; Nevins and Joklik, 1977; Spen-
cer et al., 1980), the vaccinia virus RNA polymerase
closely resembles RNA polymerases of eukaryotic and
prokaryotic organisms (Studier and Dunn, 1983). Prior
studies demonstrate that the virion form of RNA polymer-
ase bears structural and functional similarity to cellular
RNA polymerase II (Moss et al., 1991). In addition, the
vaccinia mRNA capping enzyme, was shown to bind
directly to its cognate viral RNA polymerase in solution
(Broyles and Moss, 1987; Hagler and Shuman, 1992),
which is consistent with the presence of a transcription/
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Katsafanas and Moss (1999) demonstrated that the vac-
cinia virus-encoded capping enzyme, early transcription
factor, and nucleoside triphosphate phosphohydrolase I
specifically co-eluted with a histidine-tagged RNA poly-
merase, consistent with their physical association. The
fact that J3R, the small subunit of vaccinia poly(A) poly-
merase, is involved in both polyadenylation and capping
processes, raises the possibility that its association with
NPH I and the H4L subunit of the virion RNA polymerase
serves as a docking site for J3R in its role in RNA
processing. Further studies are underway to test the
essential features of this model.
MATERIALS AND METHODS
Cells and viruses
The African green monkey kidney cell line BSC40 and
conditions for cell culture have been previously de-
scribed (Condit and Motyczka, 1981; Condit et al., 1983).
he J3R-fs mutant virus, J3-7, and the conditions for its
growth, infection, and plaque titration have been previ-
ously described (Latner et al., 2000). J3-7 is phenotypi-
cally isatin-b-thiosemicarbazone-dependent (IBTd) and
contains a single nucleotide deletion in the J3R gene that
causes a frameshift at codon 49 and truncation of the
333-amino-acid protein at position 58. IBT was prepared
fresh before each use and applied at a final concentra-
tion of 45 mM as previously described (Pacha and Con-
it, 1985).
ranscription extracts
Extracts of virus-infected cells were prepared by lyso-
ecithin treatment as described (Condit et al., 1996). A549
cells were infected with J3-7, an IBT-dependent mutant,
at a m.o.i. of 15, at 37°C in the presence of 45 mM IBT.
After 24 h, cells were washed and treated with 250 mg/ml
lysolecithin and extracts prepared.
Transcription termination assay
Termination of early gene transcription was monitored
by using a plasmid template, pSBterm (Condit et al.,
1996), which possess tandem termination signals within
the G-less cassette. Transcription reactions were carried
out in 20 ml total volume containing 6 ml extract, 1 mM
ATP, 0.1 mM UTP, 20 mM CTP, 4 mCi [a-32P]CTP (800
Ci/mmole), 0.1 mM 39OMeGTP, 0.2 mg supercoiled plas-
mid DNA, 20 mM Tris buffer, pH 8.0, 6 mM MgCl2, 2 mM
dithiolthreitol, and 8% glycerol for 30 min at 30°C. After
proteinase K treatment, RNA was isolated by extraction
with phenol/chloroform, precipitated with isopropanol,
and resuspended in formamide dye. Samples were
heated at 90°C, separated by electrophoresis in 5%
acrylamide 8 M urea gels, and the RNA was visualized
by autoradiography. Termination efficiency was calcu-lated as the molar ratio of terminated RNA to the sum of
read through and terminated RNA.
Transcript release assay
Construction of the G21(TER29)A78 plasmid contain-
ing a vaccinia early promoter was described by Deng et
al. (1996). The prototype G21(TER29)A78 transcription
unit consists of a synthetic early promoter fused to a
20-nucleotide G-less cassette, which is flanked by a run
of three G residues at positions 121 to 123. A 57-
nucleotide A-less cassette was inserted downstream of
the G-less cassette and flanked at its 39 end by four A
residues at positions 178 to 181. A termination signal,
TTTTTTTTT, was placed within the A-less cassette, span-
ning position 129 to 137. The biotinylated 324 bp DNA
template was PCR amplified employing a 59 biotin tag on
the upstream primer and isolated by preparative agarose
gel electrophoresis. The purified DNA fragment was then
immobilized to streptavidin-coated magnetic beads
(Dynabeads M280; Dynal) as described (Hagler et al.,
1994). The bead bound (B) template (typically, 100 fmol)
was first incubated with 6 ml of J3R-fs virus-infected cell
extract in the presence of 1 mM ATP, 4 mCi a32P-CTP (800
Ci/mmol), 0.1 mM UTP, and 0.625 mM 39OMeGTP to
synthesize the G21 transcript. The ternary complex was
then isolated and the nascent transcript was extended
through the A-less cassette, in the presence of 1 mM
UTP, 1 mM GTP, 4 mCi a32P-CTP, and 1 mM cordycepin
triphosphate (39dATP), to yield a bead-bound ternary
complex containing the A78 transcript. Elongation of the
nascent chains beyond the arrest site at G21 depends on
removal of the blocking 39OMeGMP moiety by the hy-
drolytic activity intrinsic to the vaccinia RNA polymerase
elongation complex (Hagler and Shuman, 1993). The
ternary complexes were collected by centrifugation and
resuspended, and transcript release from the paused
ternary complex was then assessed (Deng et al., 1996) in
the presence or absence of VTF, trx-J3R, or mal-E1L. After
incubation for 10 min at 30°C, the bound transcript was
separated from the free by centrifugation and analyzed
by gel electrophoresis. The percent of RNA released was
quantified by scanning the autoradiogram with a Phos-
phorImager.
Plasmids
pGEX 4T1-D11L plasmids containing either full-length
or truncated D11L (NPH I) coding sequence were de-
scribed (Christen et al., 1998). pET-30a-D11L457-631 was
constructed by excising the C-terminal coding region
from pGEX 4T1-D11L by restriction digestion using
EcoRV and SalI restriction enzymes and then inserting
the DNA fragment into pET-30a vector digested with the
same enzymes. pET-42a-H4L and pCITE-4a-H4L plas-
mids containing full-length H4L were constructed by in-
serting a NcoI–SalI DNA fragment derived from pET-14a-
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coding sequence of H4L, into the NcoI–SalI digested
pET-42a and pCITE-4a, respectively. A series of H4L
truncation mutations in pCITE-4a was constructed by
restriction digestion of the original pCITE-4a-H4L con-
struct with AccI, BglII, HincII, SpeI, or MscI–SnaBI restric-
tion enzymes and religation of the digested construct.
This gave rise to a series of H4L C- and N-terminal
truncations representing amino acids, 1–195, 1–288,
1–338, 1–577, and 235–795. A series of 59 and 39 primers
derived from different regions of J3R coding sequence
was employed to amplify a battery of J3R truncation
mutants (representing amino acids, 1–81, 1–167, 1–249,
83–333, 169–333, and 252–333) using a proofreading
polymerase Pfu. The amplified blunt-end PCR fragments
were ligated into pCR-Blunt II-TOPO plasmid vector (Shu-
man, 1994). The truncated J3R fragments were then ex-
cised using NcoI–SalI restriction digestion and ligated
into both pCITE-4a and pET-42a plasmids linearized with
the same enzymes.
Resin preparation
Large-scale inductions of E. coli expressing a GST-
fusion of wild-type NPH I or NPH I truncation mutations
were carried out at 20°C as described previously (Hig-
man et al., 1992). Cells were collected by centrifugation
and stored at 280°C until used. GST-NPH I fusions were
then purified from an S100 fraction of the induced cells
by batchwise affinity to glutathione–Sepharose. Large-
scale inductions of His-GST fusion of wild-type J3R as
well as truncation mutations, were carried out at 20°C
using 0.5 mM IPTG. Cells were collected by centrifuga-
tion and stored at 280°C until used. His-GST fusions
were then purified from an S100 fraction of the induced
cells by batchwise affinity to Glutathione Sepharose. In
case of NPH I457-631, the His6-tagged fusion was isolated
by batchwise affinity to Ni–agarose. The protein-bound
resins were tested by SDS–PAGE, and the volume used
was adjusted, whenever required, by dilution with the
respective resin to yield equivalent amounts of each
protein. Resins were kept as 50% slurry at 220°C.
In vitro transcription/translation
Novagen Single Tube Protein system 3 (STP3) was
used for the in vitro synthesis of 35S-labeled proteins
irectly from DNA templates containing T7 RNA polymer-
se promoter. The DNA template (typically 0.5 mg) was
transcribed in 10 ml at 30°C for 15 min followed by the
addition of 40 ml translation mix and continued incuba-
tion for 60–90 min. Both pCITE-4a- and pET-30a-derived
recombinant plasmids were used.
In vitro protein–protein interaction assay
The proteins were labeled in vitro with [35S]methionine
y the STP3 in vitro translation system, from Novagen.ne microliter of the translation mix was incubated with
5 ml of glutathione–Sepharose or Ni-charged His-bind
resins coupled to 1 mg of the protein of interest at 4°C
vernight in binding buffer [25 mM Tris–HCl, pH 8.0, 1
M EDTA, 10% glycerol (w/v), 50 mM NaCl]. After bind-
ng, the resin was washed four times, each with 500 ml of
inding buffer. In case of Ni-charged His-bind resins, 50
M imidazole was included in the buffer during the wash
tep. The washed resins were then boiled in 13 SDS-
oading buffer (62.5 mM Tris–HCl, pH 6.8, 2% SDS, 10%
lycerol, 0.72 M b-mercaptoethanol) for 5 min and ana-
lyzed by SDS–polyacrylamide gel electrophoresis (SDS–
PAGE). The gel was then soaked in 1 M salicyclic acid for
30 min and dried, and autoradiography was then per-
formed at 280°C. The percent binding was quantified by
scanning the autoradiogram with a PhosphorImager. Un-
less otherwise stated, the background values of between
1 and 3% were subtracted, yielding the resulting percent-
age of specific binding.
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